1. Home
  2. CRON vs MYGN Comparison

CRON vs MYGN Comparison

Compare CRON & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • MYGN
  • Stock Information
  • Founded
  • CRON N/A
  • MYGN 1991
  • Country
  • CRON Canada
  • MYGN United States
  • Employees
  • CRON N/A
  • MYGN N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CRON Health Care
  • MYGN Health Care
  • Exchange
  • CRON Nasdaq
  • MYGN Nasdaq
  • Market Cap
  • CRON 684.7M
  • MYGN 744.7M
  • IPO Year
  • CRON N/A
  • MYGN 1995
  • Fundamental
  • Price
  • CRON $1.98
  • MYGN $3.89
  • Analyst Decision
  • CRON Buy
  • MYGN Hold
  • Analyst Count
  • CRON 1
  • MYGN 16
  • Target Price
  • CRON $3.50
  • MYGN $16.63
  • AVG Volume (30 Days)
  • CRON 1.8M
  • MYGN 3.0M
  • Earning Date
  • CRON 05-08-2025
  • MYGN 05-06-2025
  • Dividend Yield
  • CRON N/A
  • MYGN N/A
  • EPS Growth
  • CRON N/A
  • MYGN N/A
  • EPS
  • CRON 0.12
  • MYGN N/A
  • Revenue
  • CRON $124,589,000.00
  • MYGN $831,300,000.00
  • Revenue This Year
  • CRON $25.49
  • MYGN $2.96
  • Revenue Next Year
  • CRON $7.45
  • MYGN $8.36
  • P/E Ratio
  • CRON $15.32
  • MYGN N/A
  • Revenue Growth
  • CRON 33.92
  • MYGN 7.38
  • 52 Week Low
  • CRON $1.60
  • MYGN $3.98
  • 52 Week High
  • CRON $3.14
  • MYGN $29.30
  • Technical
  • Relative Strength Index (RSI)
  • CRON 62.87
  • MYGN 17.24
  • Support Level
  • CRON $1.81
  • MYGN $6.94
  • Resistance Level
  • CRON $2.06
  • MYGN $7.81
  • Average True Range (ATR)
  • CRON 0.07
  • MYGN 0.50
  • MACD
  • CRON 0.02
  • MYGN -0.29
  • Stochastic Oscillator
  • CRON 76.92
  • MYGN 0.74

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: